Literature DB >> 11581248

Enhanced decrease of blood colony counts by specific anti-pneumococcal antibodies in the presence of sub-inhibitory concentrations of amoxicillin.

J Yuste, M J Giménez, I Jado, A Fenoll, L Aguilar, J Casal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11581248     DOI： 10.1093/jac/48.4.594

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

1.  Combined effect of specific antibodies (as serotherapy or preimmunization) and amoxicillin doses in treatment of Streptococcus pneumoniae sepsis in a mouse model.

Authors:  J Yuste; A Fenoll; J Casal; M J Giménez; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

2.  Effects of amoxicillin subinhibitory concentrations on the cross-protection developed by pneumococcal antibodies in mouse sepsis caused by an amoxicillin-resistant serotype 6B Streptococcus pneumoniae strain.

Authors:  D Tarragó; L Aguilar; M J Giménez; A Fenoll; J Casal
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

3.  Macrolides and β-lactam antibiotics enhance C3b deposition on the surface of multidrug-resistant Streptococcus pneumoniae strains by a LytA autolysin-dependent mechanism.

Authors:  Elisa Ramos-Sevillano; Cinthya Rodríguez-Sosa; Roberto Díez-Martínez; María-José Giménez; Eduardo Olmedillas; Pedro García; Ernesto García; Lorenzo Aguilar; Jose Yuste
Journal:  Antimicrob Agents Chemother       Date:  2012-08-13       Impact factor: 5.191

Review 4.  Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract.

Authors:  Mirian Domenech; Julio Sempere; Sara de Miguel; Jose Yuste
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

5.  C-Reactive Protein-Based Strategy to Reduce Antibiotic Dosing for the Treatment of Pneumococcal Infection.

Authors:  Donald N Ngwa; Sanjay K Singh; Alok Agrawal
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 8.786

6.  Cefditoren and ceftriaxone enhance complement-mediated immunity in the presence of specific antibodies against antibiotic-resistant pneumococcal strains.

Authors:  Elisa Ramos-Sevillano; Cinthya Rodríguez-Sosa; Fabio Cafini; Maria-Jose Giménez; Ana Navarro; David Sevillano; Luis Alou; Ernesto García; Lorenzo Aguilar; Jose Yuste
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.